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Previewsare likely the highly-glycosylated mucous
proteins, which ovalbumin injected into
the intestine more closely mimics.
On a more theoretical note, one might
askwhat purpose is served by the division
of labor between macrophages and
DCs—why can’t the DCs take up the anti-
gen, or conversely, the macrophages
carry it to lymph nodes? Here Mazzini
et al. speculate that this relay race might
serve to prevent DCs from contacting
the gut microbiota and becoming need-
lessly activated. Because the DCs have
also been observed sending extensions
into the lumen, and because transfer of
antigens between myeloid cells has also
been documented in other settings
(Allan et al., 2006), this might not be thewhole story. Regardless, Mazzini and col-
leagues have revealed that in the case of
developing tolerance to ingested nutri-
ents, food antigens must mind the gap.REFERENCES
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Ourmolecularunderstandingofhowpathogen-microbiota-immunesystem interactions influencediseaseout-
comes is limited. In this issue of Immunity, Behnsen et al. (2014) report that the cytokine interleukin-22, which
usually plays a protective role, promotes pathogen colonization by suppressing related commensal bacteria.We are beginning to understand the
complex interplay between mammalian
immune systems, indigenous microbial
communities and microbial pathogens at
a molecular level. The human gut is
teeming with trillions of bacteria that are
essential for themaintenanceofourhealth.
For example, commensal bacteria are key
participants in the digestion of food and
extract nutrients and other metabolites
that we need to stay healthy. Many of the
metabolites and nutrients that commensal
bacteria provide are implicated in the
development, homeostasis and function
of our immune system. Thus, our indige-
nous gut bacteria can provide protection
to invading pathogens by influencing
immune and nutritional barriers. In addi-
tion, commensal bacteria can provide
increased resistance to bacterial patho-
gens by occupying their required niche.
However, many bacterial pathogens havethe capacity to disrupt or bypass homeo-
static, immune, and colonization resis-
tance mechanisms (Sansonetti, 2011). In
this issue of Immunity, Behnsen et al.
(2014) explore the complex interactions
between an important mucosal immune
factor, the commensal bacteria and the
enteric pathogen Salmonella enterica se-
rovar Typhimurium (referred asSalmonella
from here on) in the guts of mice.
Salmonella is an important food-borne
pathogen that causesa self-limitedgastro-
enteritis in humans. The mucosal immune
response toSalmonella, aswithotherpath-
ogens, is orchestrated by T cells that ex-
press the cytokines interleukin-17 (IL-17)
and IL-22. IL-17 promotes the recruitment
of neutrophils and prevents the dissemina-
tionofSalmonella to the reticuloendothelial
system. IL-22 is produced by immune
cells, including T-helper cell subsets and
innate lymphocytes, but acts only on non-hematopoietic stromal cells; in particular
epithelial cells, keratinocytes, and hepato-
cytes (Rutz et al., 2013). IL-22 is usually
beneficial to the host because it elicits the
expression of proinflammatory epithelial
defense mechanisms that are essential
for host protection. IL-22 promotes epithe-
lial proliferation and helps to maintain and
restore the integrity of the epithelial barrier
function during the invasion by pathogens.
In addition, IL-22 synergizes with other cy-
tokines, such as IL-17 or tumor necrosis
factor-a (TNF-a), to induce expression of
antimicrobial proteins involved in host de-
fense in the skin, the airways, and the intes-
tine. For example, IL-22 induces the
expression of S100A7, S100A8, S100A9,
b-defensin-2, and b-defensin-3 in the
skin. It also promotes the release of RegIIIb
and RegIIIg from intestinal cells and stimu-
lates the production of protective mucus
(Muc1, Muc3, Muc10, and Muc13) fromFebruary 20, 2014 ª2014 Elsevier Inc. 173
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Figure 1. Salmonella Exploits IL-22-Mediated Nutritional Immune Mechanisms to
Outcompete Escherichia coli in the Gut
In the gut, APCs are activated by Salmonella to produce IL-23, which engages T cells and other cell types
to produce IL-22. IL-22 binds to receptors on colonocytes and promotes production of antimicrobial
molecules including lipochalin and two subunits of calprotectin. Lipochalin and calprotectin bind metal
ions, which are essential for bacterial replication. However, Salmonella expresses proteins (salmochelin
and ZnuABC) that can steal metal ions from lipochalin and calprotectin and thus successfully out-
compete its nearest neighbors, E. coli and other gut flora. In IL-22-deficient mice, there are fewer
antimicrobial factors expressed and both Salmonella and E. coli colonize the gut.
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Previewsgoblet cells. Lastly, IL-22 promotes the
production of inflammatory mediators,
such as IL-6, G-CSF, and IL-1b, and plays
a role in the releaseof chemokines, suchas
CXCL1, CXCL5, and CXCL9, from airway
epithelial cells during infection (Rutz et al.,
2013).
Salmonella thrives in the inflamed
gut and successfully outcompetes the
microbiota by mechanisms that are not
completely understood (Winter et al.,
2013). Behnsen et al. set out to elucidate
the role of IL-22 during Salmonella infec-
tion in the gut of mice and quite surpris-
ingly demonstrated that IL-22 does not
play a protective role, but instead is ex-
ploited by this pathogen in order to cause
gastroenteritis. Behnsen et al. orally
infected streptomycin pretreated IL-22-
deficient mice with Salmonella and found
that the intestines of these mice con-
tained significantly fewer Salmonella
compared to the wild-type (WT) mice.
Importantly, they could rescueSalmonella
colonization by injecting infected Il22/
mice with IL-22. This result was surprising
because IL-22 has been shown to play a
protective role in the guts of mice
against Citrobacter rodentium, against
vancomycin-resistant Enterococcus (Kin-
nebrew et al., 2010; Zheng et al., 2008),
and against Klebsiella pneumonia in
the lungs of mice (Aujla et al., 2008).
Because previous studies suggested
that Salmonella achieves high levels of
colonization of the gut only when this174 Immunity 40, February 20, 2014 ª2014 Eorgan is inflamed, the authors wondered
whether the IL-22-deficient mice had
less inflammation, which would explain
the reduced Salmonella colonization.
However, this was not the case and the
differences in the levels of pathogen
colonization cannot be explained by dif-
ferences in the levels of inflammation.
Because Salmonella needs to compete
with the microbiota in order to colonize
the inflamed gut (Winter et al., 2013), the
authors explored the possibility that
the established microbiota is different in
the absence of IL-22. When Behnsen
et al. analyzed the gut microbiota com-
positions of uninfected WT and Il22/
mice, they did not detect any significant
differences. In contrast, Proteobacteria
bloomed in the inflamed gut of both WT
and Il22/mice infectedwithSalmonella.
However, there was a considerable
difference in the relative abundance of
the genera Salmonella and Escherichia
in the guts of these mice. While Salmo-
nella constituted 50% of the total
bacteria in infectedWTmice, it comprised
15% in the IL-22-deficient mice, whereas
Escherichia constituted 40% of Proteo-
bacteria. These results indicated that,
in the absence of IL-22, commensal En-
terobacteriaceae can compete with Sal-
monella in the inflamed gut.
What is the mechanism? IL-22 regu-
lates antimicrobial responses (Rutz
et al., 2013), such as the expression of
lipocalin-2, which sequesters the sidero-lsevier Inc.phore enterochelin and inhibits growth
of Enterobacteriaceae; S100a8 and
S100a9, which are two subunits of calpro-
tectin, an antimicrobial protein that
sequesters zinc and manganese from
pathogens; and enzymes that play a role
in the generation of reactive nitrogen and
oxygen species (iNOS and Duox2). The
authors found that the expression of
genes encoding metal binding proteins
(Lcn2, S100a8, and S100a9) and those
encoding proteins involved in the genera-
tion of reactive oxygen and reactive nitro-
gen species (Nos and Duox2) were signif-
icantly reduced in Salmonella -infected
Il22/ mice. Because Salmonella
possess multiple virulence mechanisms
that mediate resistance to specific antimi-
crobial proteins (Liu et al., 2012; Raffatellu
et al., 2009; Stelter et al., 2011) and allow
it to thrive in the inflamed gut (Winter
et al., 2013), the authors speculated that
Salmonella was surviving IL-22-depen-
dent killing mechanisms to outcompete
Escherichia in the guts of WT mice. How-
ever, in the absence of IL-22, the indige-
nous Escherichia could get the upper
hand. To test this notion, Behnsen et al.
assessed whether IL-22 enhances the
colonization of Salmonella over isogenic
mutant strains with known susceptibilities
to IL-22-dependent antimicrobial pro-
teins. To overcome calprotectin-medi-
ated zinc sequestration by the host,
Salmonella acquires iron with the sidero-
phore salmochelin. Mutants in the salmo-
chelin receptor are susceptible to iron
sequestration by lipocalin-2 in the
inflamed gut (Raffatellu et al., 2009).
Salmonella overcomes another host
defense mechanism mediated by calpro-
tectin sequestration of zinc by transport-
ing this essential metal via the high affinity
ZnuABC system (Liu et al., 2012). To test
the idea that these Salmonella virulence
mechanisms are utilized to exploit IL-22-
dependent immune mechanisms, the
authors infected mice with mixtures of
Salmonella mutants in these pathways
(e.g., iroN and znuA deletion mutants)
and show that they lose their growth
advantage over commensal E. coli.
When iron and zinc availability was limited
by lipochalin-2 and calprotectin, iron
acquisition through salmochelin and zinc
acquisition through the ZnuABC trans-
porter greatly enhanced the competitive
advantage of Salmonella in the intestine
of WT mice (Figure 1). However,
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PreviewsSalmonella loses its competitive advan-
tage in the guts of Il22/ mice where lip-
ocalin-2 and calprotectin levels are
reduced. Thus, Salmonella exploits IL-
22, a key regulator of nutritional immunity,
which starves microorganisms from
essential metal nutrients, by expressing
virulence factors that allow it to sequester
these nutrients and outcompete
commensal Enterobacteriaceae, its
closest relative in the intestine.
In the future, it will be very important to
determine whether IL-22, a key regulator
of nutritional immunity, benefits other
mucosal pathogens by similar mecha-
nisms, i.e., by inducing antimicrobial
responses that suppress the growth of
the microbiota, thereby enhancing their
colonization. It will also be important toidentify additional IL-22-dependent anti-
microbial factors. Finally, these findings
suggest that specific targeting of viru-
lence mechanisms that promote evasion
of IL-22-mediated host defenses is a
viable strategy to harness and control
mucosal pathogens.REFERENCES
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Macrophage activation is a crucial process for innate immunity as well as for tissue and metabolic homeo-
stasis. In this issue of Immunity, Xue et al. (2014) extend our knowledge on macrophage activation and
identify unique functional states, thus expanding the M1-M2 paradigm.An essential requisite for macrophages to
be able to exert their physiological func-
tions is to accurately recognize and clas-
sify microenvironmental changes, in order
to properly react to such challenges and
also to coordinate both local and general
responses. A critical component of this
environmental response is often a broad
transcriptional reprogramming involving
hundreds of protein-coding and noncod-
ing genes, a process whose final aim is
the expression of gene products relevant
to cope with possible emergencies
(Smale, 2010). Although invading micro-
organisms represent the most relevant
emergency that macrophages usually
deal with, these cells also exert complex
roles during development, tissue remod-
eling, and sterile damage repair (Wynn
et al., 2013). Particularly in the case ofsystemic infections, the efficient removal
of microorganisms often requires com-
plex metabolic changes in the entire
organism, explaining the extensive cross-
talk between macrophages and cells of
metabolic organs (Hotamisligil, 2006).
Although these notions are well-estab-
lished, a comprehensive description of
macrophage activation states is not yet
available, not to mention the fact that a
rational understanding of their functional
implications and the underlying mecha-
nisms remain far from being fully charac-
terized. The classical macrophage activa-
tion (‘‘polarization’’) states M1 and M2
(corresponding to inflammatory macro-
phages induced by interferon-g [IFN-g]
and alternatively activated macrophages
induced by interleukin-4 [IL-4], respec-
tively) (Gordon and Martinez, 2010) are infact useful to describe extreme states to-
ward which macrophages can be driven
by stimulation (Biswas and Mantovani
2010). However, as it has been recognized
formany years, these two states are insuf-
ficient to describe the much broader
complexity of stimuli and responses that
mark the normal life of a macrophage.
Therefore, attempts to systematically
explore macrophage activation via tran-
scriptomic and systems biology tools are
highly valuable and commendable efforts.
In their study, Xue and coworkers inves-
tigated the transcriptional changes trig-
gered in humanmonocyte-derivedmacro-
phages by 28 different stimuli (or their
combinations), thus generating almost
300 data sets (Xue et al., 2014). One
extreme yet informative example of speci-
ficity was the identification of a smallFebruary 20, 2014 ª2014 Elsevier Inc. 175
